Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Spruce Biosciences Inc
(NQ:
SPRB
)
0.4774
+0.0200 (+4.37%)
Streaming Delayed Price
Updated: 3:52 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Spruce Biosciences Inc
< Previous
1
2
3
4
5
6
7
Next >
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q2 2024
August 12, 2024
SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Spruce Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
August 12, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Major Potential: 5 NASDAQ / NYSE Stocks Under $1 SGMO, FTCI, VTAK, SPRB, DNA
July 11, 2024
Via
AB Newswire
Spruce Biosciences Recognized as a Bay Area Best Place to Work
June 06, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder
June 04, 2024
Spruce Biosciences collaborates with HMNC Brain Health to advance tildacerfont, a precision therapeutic for major depressive disorder, using the Cortibon Genetic Selection Tool.
Via
Benzinga
Spruce Biosciences and HMNC Brain Health Announce Strategic Collaboration to Develop Treatment for Major Depressive Disorder (MDD)
June 04, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
June 03, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in the Jefferies Global Healthcare Conference
May 23, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society
May 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
SPRB Stock Earnings: Spruce Biosciences Beats EPS, Beats Revenue for Q1 2024
May 13, 2024
SPRB stock results show that Spruce Biosciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
May 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in May Investor Conferences
May 01, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Pfizer Q1 Earnings and Revenues Beat Estimates
May 01, 2024
PFE came out with quarterly earnings of $0.82 per share, beating the our eimate of $0.56 per share. This compares to earnings of $1.23 per share a year ago.
Via
Talk Markets
Spruce Biosciences Announces Additional Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
April 30, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
April 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 21, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
March 14, 2024
Spruce Biosciences faces setbacks as tildacerfont trials fail primary endpoints, raising concerns about drug efficacy and compliance. Analysts downgrade ratings and adjust price targets amid...
Via
Benzinga
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 14, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
March 14, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.35% to 38,905.20 while the NASDAQ fell 0.13% to 16,156.28....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 14, 2024
Via
Benzinga
Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
March 14, 2024
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.30% to 38,926.22 while the NASDAQ fell 0.44% to 16,107.04. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
US Stocks Higher; Producer Prices Rise 0.6% In February
March 14, 2024
U.S. stocks traded higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.11% to 39,084.58 while the NASDAQ rose 0.30% to 16,226.13. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Is Altria Giving Up on Anheuser-Busch (BUD) Stock?
March 14, 2024
Anheuser-Busch stock is falling on Thursday following news that 10% holder Altria is selling a portion of its stake in BUD shares.
Via
InvestorPlace
Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?
March 14, 2024
Spruce Biosciences' latest CAH studies: CAHmelia-203 & CAHptain-205. Discover insights on tildacerfont's efficacy, safety, and pharmacokinetics in adult & pediatric CAH patients.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 14, 2024
Via
Benzinga
Why Is Fisker (FSR) Stock Down 41% Today?
March 14, 2024
Fisker stock is falling hard on Thursday as FSR investors react to reports that the EV company is preparing to file for bankruptcy.
Via
InvestorPlace
Why Is Spruce Biosciences (SPRB) Stock Down 78% Today?
March 14, 2024
Spruce Biosciences stock is falling hard on Thursday as investors in SPRB shares react to the latest clinical trial data reported.
Via
InvestorPlace
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
March 14, 2024
Shares of Robinhood Markets, Inc. (NASDAQ: HOOD) rose sharply in today’s pre-market trading after the company reported February trading metrics.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 14, 2024
It's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.